68 Ga-DOTA-IBA Uptake in Meningioma and Liver Metastasis of Breast Cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 40392191.
- Also identified by DOI 10.1097/RLU.0000000000005890.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 41-year-old woman with bone and liver metastasis of breast cancer was enrolled in our 68 Ga-labeled DOTA-ibandronic acid ( 68 Ga-DOTA-IBA) PET/CT tumor clinical trial. The examination revealed increased uptake of 68 Ga-DOTA-IBA in the multiple bone metastases. Unexpectedly, 68 Ga-DOTA-IBA uptake in meningioma and liver metastasis were also noted.
Medical subject headings
- Breast Neoplasms
- Meningioma
- Liver Neoplasms
- Meningeal Neoplasms
- Organometallic Compounds